Clinical Trials Browser

INDUSTRY × Expanded_access × Triple Negative Breast Neoplasms × Clear all

NCT03123211 2022-05-24

Expanded Access to Veliparib

No longer available

Triple Negative Breast Neoplasms

NCT04320693 2021-08-19

Expanded Access for IMMU-132

Approved for marketing

Triple Negative Breast Neoplasms

NCT01130259 2013-09-17

An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

No longer available

Breast Neoplasms, Triple Negative Breast Neoplasms